Skip to content
10-Q

Quarterly Report

ACRO BIOMEDICAL CO., LTD. ACBM

0001640334-26-000824

← back to feed
Filed
May 5, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 28, 2026 60.04M sh
Shares Diluted Q1 2026 · Mar 31, 2026 60.04M sh
Shares Diluted Q1 2026 · Mar 31, 2025 60.04M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$49.82K
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$22.53K
Stockholders Equity Q1 2026 · Mar 31, 2026 −$427.24K
Stockholders Equity Q1 2026 · Dec 31, 2025 −$386.96K
Stockholders Equity Q1 2026 · Mar 31, 2025 −$303.91K
Stockholders Equity Q1 2026 · Dec 31, 2024 −$294.97K
Current Liabilities Q1 2026 · Mar 31, 2026 $431.11K
Current Liabilities Q1 2026 · Dec 31, 2025 $401.06K
Current Assets Q1 2026 · Mar 31, 2026 $3.87K
Current Assets Q1 2026 · Dec 31, 2025 $14.1K
Total Assets Q1 2026 · Mar 31, 2026 $3.87K
Total Assets Q1 2026 · Dec 31, 2025 $14.1K
Eps Diluted Q1 2026 · Mar 31, 2026 $0.00
Eps Diluted Q1 2026 · Mar 31, 2025 $0.00
Sga Expense Q1 2026 · Mar 31, 2026 $60.27K
Sga Expense Q1 2026 · Mar 31, 2025 $8.93K
Net Income Q1 2026 · Mar 31, 2026 −$43.77K
Net Income Q1 2026 · Mar 31, 2025 −$10.3K
Operating Income Q1 2026 · Mar 31, 2026 −$60.27K
Operating Income Q1 2026 · Mar 31, 2025 −$8.93K
Revenue Q1 2026 · Mar 31, 2026 $0
Revenue Q1 2026 · Mar 31, 2025 $0